Ironwood Pharmaceuticals

$8.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-1.58%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IRWD and other stocks, options, ETFs, and crypto commission-free!

About IRWD

Ironwood Pharmaceuticals, Inc. Class A Common Stock, also called Ironwood Pharmaceuticals, is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Read More Its products include linaclotide, a guanylate cyclase type-C agonist which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller in 1998 and is headquartered in Cambridge, MA.

Employees
515
Headquarters
Cambridge, Massachusetts
Founded
1998
Market Cap
1.36B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.78M
High Today
$9.13
Low Today
$8.69
Open Price
$8.81
Volume
1.44M
52 Week High
$16.44
52 Week Low
$7.59

Collections

IRWD News

ReutersAug 3

Edited Transcript of IRWD earnings conference call or presentation 30-Jul-19 8:30pm GMT

5

IRWD Earnings

-$0.38
-$0.22
-$0.06
$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours

More IRWD News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.